Mutations in IDH1 and IDH2 genes lead to increased production of D-2 hydroxy-glutarate (2HG), contributing to the development of various malignancies such as acute myeloid leukemia, chondrosarcoma, cholangiocarcinoma, and glioma [34,35,36]. This evidence concerns the gene IDH1 and acute myeloid leukemia.